Bionexus Gene Lab Corp · NASDAQ:BGLC
Tan Lee Su-Leng received 338,709 Bionexus Gene Lab Corp shares as an award (Form 4)
Traded Aug 13, 2026 · Filed Aug 14, 2026
On Aug 13, 2026, Tan Lee Su-Leng (Director, Chief Executive Officer, 10% owner) received 338,709 Bionexus Gene Lab Corp shares as an award, leaving 338,709 shares. Filed Aug 14, 2026 (Form 4).
- Awarded
- 338,709 shares
- Holding after
- 338,709 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Common Shares | Award | 338,709 | 338,709 | Direct |